fatty acids, which also inhibit glucose utilisation when no insulin is present in the medium.
The insulin antagonist that has interested us is that associated with plasma-albumin and which, because of this, has become known as the synalbumin insulin antagonist.
Using the rat diaphragm technique we have found that plasma-albumin from patients with essential or idiopathic diabetes, including latent or prediabetes, has more antagonism to insulin than that prepared from normal subjects or from patients with 'pancreatic' diabetes, i.e. suffering from acute pancreatitis, hremochromatosis or who have sustained total pancreatectomy.
Albumin from diabetics or from normal subjects, when tested at 3,5-5,5 %, completely inhibited the 1,0DO~u/ml. insulin added in vitro.
At 1·25 %, however, albumin from essential diabetics, whether insulin-requiring, obese or prediabetic, was still highly antagonistic whereas that from normal subjects or 'pancreatic' diabetics showed no antagonism.
Our earlier studies indicated that this antagonist was apparently dependent upon the pituitary adrenal system and was not the albumin itself but some substance associated with it, which was possibly a peptide of molecular weight below 4,DOO. This was the situation approximately two and a half years ago when Dr. John Ensinck came to work with me in Newcastle; he had become interested in the enzyme which has a major specificity for the degradation of the insulin molecule and which is concentrated mainly in the liver.
This enzyme, previously known as insulinase, has recently been isolated and charaterised. The purified enzyme, re-termed 'glutathione insulin transhydrogenase' catalyses the reductive cleavage of the disulfide bonds of insulin by glutathione, resulting in the formation of the 'A' and 'B' chains of the insulin molecule. The 'B' chain is a stable polypeptide of 3,800 molecular weight with two SH groups per molecule, but in the reduced state, it is virtually insoluble in physiological buffers. Utilizing the purified enzyme and glutathione, we have found that radio-active insulin in the presence of serum, is cleaved into two radioactive components. These two compounds, which by electrophoresis are distinguished from 131 1 insulin at their origin by their migration in the alpha-2 globulin and albumin regions, have been isolated and identified as the radio-active 'A' and 'B' chains respectively.
It has been established by other techniques that the 'B' chain, migrating with albumin electrophoretically, is, in fact, bound to albumin and that this interaction permits solubilisation of the ,B' chain in solutions at physiological pH.
In view of the extensive evidence indicating that inhibitors of a biochemical reaction are frequently structurally similar to the metabolites which stimulate the reaction, we considered that the 'B' chain might be capable of inhibiting the action of its parent molecule insulin and since it is associated with albumin, that it might be equated with the synalbumin insulin antagonist of human plasma.
We have now shown that the 'B' chain of insulin, when complexed with albumin, rendered non-antagonistic by treatment with thiol compounds or by passage through a partially acetylated cellulose column, is capable of inhibiting the effect of 1,000 uu/ml, insulin on the isolated rat diaphragm. Furthermore, the synalbumin insulin antagonist and the 'B' chain of insulin have a number of physico-chemical similarities; notably the type of bonding to albumin, molecular weight and ionic charge as well as biological activity.
Thus, at the present time, there is considerable evidence to suggest that the 'B' chain and this humoral insulin antagonist are identical.
If this can be confirmed, it seems reasonable to postulate that one of the fundamental inherited lesions in diabetes mellitus results in increased amounts of circulating 'B' chain complexed to albumin and that this abnormality may eventually be found to reside in the insulin degrading enzyme system of the liver.
The Physiology and Biochemistry of Calcitonin
I. MACINTYRE THE POSTGRADUATE MEDICAL SCHOOL, HAMMERSMITH, LONDON Perfusion Studies. Three experiments were des-low calcium blood. The results showed that a cribed. In experiment No. I, the dog thyro-serum calcium lowering agent was secreted. In parathyroid glands were perfused with high and experiment No.2, perfusion studies were con-ducted in completely parathyroidectomised dogs. The falls in systemic serum calcium, observed in the first experiment, also occurred in this case. This showed that the thyroid was involved in the secretion of calcitonin, but participation of the parathyroid glands was not excluded.
Further experiments therefore, were carried out on goats; these showed that calcitonin was of thyroid origin.
Studies of Thyroid and Parathyroid Extracts.
A bio-assay procedure was developed and used to purify a highly potent polypeptide from thyroid. No activity could be extracted from parathyroid glands. Some properties of this substance were briefly described.
Effects ofInjection of Calcitonin in the Rat. Large amounts of calcitonin were infused for 12 hours in intact rats. Tetany was usually produced and a marked fall in serum calcium, phosphate and magnesium was observed.
The electroencephalograph was recorded daily and the plasma ammonia estimated twice daily. The most marked slowing of the E.E.G. record occurred approximately 36 hours after the plasma ammonia had reached 170 ug per 100 ml. In cases of liver disease the concentration of pre-coma and at this time the plasma ammonia plasma ammonia is not directly related to the was found to be 172~g per 100 ml. The ammonia level of consciousness. Coma results when a high level fell on treatment with Neomycin and the level of ammonia persists over hours or days. patient made a good recovery. One month later Conversely, a fall in plasma ammonia heralds the patient volunteered to take capsules of subsequent recovery. For this reason, isolated ammonium acetate and sufficient was given to estimations of ammonia do not correlate with raise and maintain the level of ammonia to the the immediate conscious state but rather predict same value as was first found on admission the subsequent course of events.
NATIONAL MEETING
This time lag between a rise in the level of ammonia and its effect upon cerebral function is illustrated in the following case:
A patient was admitted to hospital in hepatic
Studies of Blood Ammonium in Respiratory Failure LoRNA O. MORRIS and G. M. ABER Studies of arterial ammonium concentration in patients with chronic obstructive airways disease have shown that this is often elevated during episodes of acute respiratory infection, returning to normal values during recovery. The possible relationship between arterial ammonium levels, and arterial gas tensions and pH was discussed.
It has been shown that although a reduction in the arterial ammonium concentration can be produced by increasing the inspired oxygen concentration in these patients, in vitro oxygenation of blood from the same patients failed to produce any change in the ammonium levels.
Measurements of the release of ammonium into the renal vein at different levels of arterial oxygenation have also been made.
The Urine Calcium/Creatinine Ratio in Hypercalcaemia M. R. WILLS DEPARTMENT OF CHEMICAL PATHOLOGY, BRISTOL ROYAL INFIRMARY The work reported was undertaken to invest-subjects and patients with disorders of calcium igate the validity of a random urine sample as a metabolism, and, in particular, to investigate the measure of urine calcium excretion in normal effect of variations in urine concentration and
